Drug intelligence / Profile preview

fusidic acid

Development stage
Phase 4
Lead developer
LEO Pharma
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Administration
Topical, Ophthalmic, Oral, Intravenous
01

Overview

Fusidic acid is a steroidal antibiotic used primarily to treat bacterial infections caused by susceptible organisms. It is most commonly applied topically as creams or ointments for skin infections such as impetigo and cellulitis, and as eye drops for conjunctivitis. Systemic formulations (oral tablets or injections) are also available but are typically reserved for hospital use. Fusidic acid acts by inhibiting bacterial protein synthesis through binding to elongation factor G (EF-G) on the ribosome after GTP hydrolysis. This prevents the necessary conformational changes required for EF-G release from the ribosome, effectively blocking translocation during protein synthesis and thus halting bacterial growth. It is bacteriostatic rather than bactericidal and has a unique mechanism of action among antibiotics. Fusidic acid was originally isolated from the fungus *Fusidium coccineum* and is considered the only marketed member of the fusidane class.

Brand names
FucidinFucibetFucithalmic
Other names
sodium fusidate
02

Targets

EF-G (Elongation factor G 1, mitochondrial)

Beyond the preview

Go deeper on fusidic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fusidic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call